Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 15 - Drugs for genital or sexual disorders; Contraceptives
Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
12/2005
12/28/2005CN1233395C Oral liquid for treating postpartum hypogalactia and its preparation
12/28/2005CN1233355C Medicine for male infertility
12/27/2005US6979691 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
12/27/2005US6979687 Theophylline-based soluble guanylyl cyclase activators KMUP-1 analogues enhanced cyclic GMP and K+ channel activities on rabbit corpus cavernosum smooth muscle and intercavernous pressure activities
12/27/2005US6979447 Immunomodulation and effect on cell processes relating to serotonin family receptors
12/27/2005CA2131911C Minimizing progestin associated breakthrough bleeding
12/22/2005WO2005097814A3 Composition and method for inhibiting platelet aggregation
12/22/2005US20050283844 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/22/2005US20050282889 Intracorporeal medicaments for photodynamic treatment of disease
12/22/2005US20050282817 4-(3-Phenyl-3-carbocycloylpropyl)-1-phenyl- or pyridylpiperazine derivatives: 1-(2-methoxyphenyl)-4-[3-(benzoyl)-3-(phenyl)propyl]piperazine oxalate; serotonin receptor antagonists; obesity
12/22/2005US20050282789 administering for treatment of metabolic bone diseases, mobilizing calcium for osteoporosis, imbalances in the immune system
12/22/2005US20050282729 Cysteine-rich secretory protein (CRISP); CRISP polypeptide inhibits tyrosine phosphorylation of sperm proteins; inhibiting sperm fertilizing-ability without affecting the hormonal balance in male or females
12/22/2005US20050282255 Cell growth differentiation factor (MP52) for use in treatment and prevention of nervous system, dental, skin, connective tissue and bone disorders; wound healing agents
12/22/2005US20050282165 Diagnosis of Carcinoma Using RAIG1 Polypeptides
12/22/2005CA2570046A1 Substituted triazole derivatives as oxytocin antagonists
12/21/2005EP1606307A1 ESTRIENO(3,2-b)/(3,4-c)PYRROLE DERIVATIVES USEFUL AS MODULATORS OF THE ESTROGEN RECEPTORS
12/21/2005EP1606281A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
12/21/2005EP1606278A1 Substituted cyclohexyl and piperidinyl derivates as melanocortin-4 receptor modulators
12/21/2005EP1606272A1 3-(1-3-(1,3-benzothiazol-6-yl)propylcarbamoyl cycloalkyl)propanoic acid derivatives as nep inhibitors
12/21/2005EP1605949A2 Mesoprogestins (progesterone receptor modulators) as a component of female contraceptives
12/21/2005EP1605948A1 Prostaglandin compositions for the treatment of erectile dysfunction
12/21/2005EP1605928A1 Compositions and methods for treatment of premature ejaculation
12/21/2005EP1463728A4 Fused cyclic modulators of nuclear hormone receptor function
12/21/2005EP1458723A4 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function
12/21/2005EP1265859B1 Amidino compounds useful as nitric oxide synthase inhibitors
12/21/2005EP1223915B1 Dry powder compositions having improved dispersivity
12/21/2005EP1222200B1 Fusion protein between HPV-L1 and a peptide, capable of forming a VLP and that functions as a vehicle for introduction of a peptide in a cell and medical uses thereof
12/21/2005EP1196442B1 Vgf polypeptides and methods of treating vgf-related disorders
12/21/2005EP1178973B1 Pyrazinyl-piperazine- compounds, their use and preparation
12/21/2005EP1102768B1 Substituted pyrazole derivatives condensed with six-membered heterocyclic rings
12/21/2005EP0579819B1 Novel pyridone derivative having an affinity for the angiotensine ii receptor
12/21/2005CN1711235A New phenyl-naphthalene derivatives, and preparation method and drug containing same
12/20/2005US6977264 For therapy and prophylaxis of obesity, diabetes
12/20/2005US6977254 For prevention and/or suppression of preterm labor, suppression labor at term prior to caesarean deliver, and for the treatment of dysmenorrhea, useful in enhancing fertility rates
12/20/2005US6977242 Two gonadotropin releasing hormones and a method to isolate the same
12/20/2005CA2324324C Treatment of pulmonary hypertension
12/15/2005WO2005118811A1 Novel polypeptide useful for diagnosis and treatment of cancer
12/15/2005WO2005118556A1 Propane-1,3-dione derivative or its salt
12/15/2005WO2005117934A1 Sustained release composition
12/15/2005US20050277678 5-(4-Fluorophenyl)-1-(4-methylsulfoximinylphenyl)-3-trifluoromethyl-1H-pyrazole; prostaglandin and cyclooxygenase inhibitor; antiinflammatory, analgesic, and antipyretic agent
12/15/2005US20050277660 Novel tetrahydroquinoline derivatives
12/15/2005US20050277652 Hepatocyte growth factor receptor inhibitors; Antitumor agents, anticarcinogenic agents, angiogenesis inhibitors; pyrimidine derivatives like Pyrrolidine-1-carboxylic acid [6-(2-fluoro-4-{3-[2-(4-fluorophenyl)acetyl]thioureido}phenoxy)pyrimidin-4-yl]amide
12/15/2005US20050277646 N-[4-({5-(4-fluorophenyl)-4-[4-(trifluoromethyl)phenyl]pyridin-2-yl}oxy)-1,3-benzothiazol-2-yl]acetamide; vanilloid (capsaicin) receptor antagonist/agonist; antiinflammatory, analgesic, antiarthritis, antirheumatic; diseases involving sensory nerve function
12/15/2005US20050277627 Colchinol derivatives as vascular damaging agents
12/15/2005US20050276821 Antigen protein and nucleic acid coding for said protein
12/15/2005DE102004026669A1 Verwendung einer Kombination aus Ethinylestradiol und Chlormadinonacetat zur Herstellung eines Arzneimittels Use of a combination of ethinyl estradiol and chlormadinone acetate in the manufacture of a medicament
12/15/2005CA2568641A1 Sustained release composition
12/14/2005EP1604983A1 Receptor antagonist
12/14/2005EP1604982A1 Intermediates for the preparation of piperidine derivatives useful as modulators of chemokine receptor activity
12/14/2005EP1604682A1 Gonadal function improving agents
12/14/2005EP1603912A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
12/14/2005EP1603911A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
12/14/2005EP1603535A2 Aromatase inhibitor diagnosis and therapy
12/14/2005EP1509228B1 Derivatives of 2-(1-benzyl-1h-pyrazolo (3, 4-b)pyridine-3yl) -5-(4-pyridinyl)-4-pyrimidine amine and the use thereof as guanylate cyclase stimulators
12/14/2005EP1450786B1 Isoflavone concentrate and method for production thereof
12/14/2005EP1440052B1 Benzamide derivatives as antagonists of orexin receptors
12/14/2005EP1112255B1 4,4-biarylpiperidine derivatives with opioid receptor activity
12/14/2005EP0920504B1 Class e voltage-gated calcium channel antagonist and methods
12/14/2005CN1231483C 8-Azabicyclo [3.,2.1] Oct-2-Ene and-Octane derivatives
12/14/2005CN1231479C Naphthostyrils compounds
12/14/2005CN1231473C Substituted arylpyrazines
12/14/2005CN1231458C Novel aryloxy-alkyl-dialkylamines compound
12/14/2005CN1231257C Use of preparing medicine for raising genitality of female animals with long PENTRAXIN PTX 3
12/14/2005CN1231252C Medicine for treatnig ovarian cyst
12/14/2005CN1231248C Chinese medicine for reinforcing kidney and supporting yang
12/14/2005CN1231247C Medicine for miscarriage prevention and setting contraceptive ring
12/14/2005CN1231228C Drug moxibustion product with effect of promoting flow of qi and blood circulation and assuaging pain
12/14/2005CN1231217C Medicine for treating climacteric syndrome
12/14/2005CN1231210C Progesterone capsule composition and preparation thereof
12/13/2005US6974839 Method of delaying ejaculation
12/13/2005US6974837 Compositions comprising sibutramine metabolites in combination with phosphodiesterase inhibitors
12/13/2005US6974826 such as 3-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-4-methoxybenzylidene-2,4-thiazolidinedione; Hodgkin's disease
12/08/2005WO2005116027A2 Indazole and indolone derivatives and their use as pharmaceuticals
12/08/2005WO2005115426A1 Drug for ameliorating male climacteric disorder
12/08/2005WO2005115402A1 Use of a combination of ethinyl estradiol and chlormadinone acetate for the production of a medicament
12/08/2005WO2005115369A2 Use of ppar agonists to treat ruminants
12/08/2005WO2005054432A3 Gene transfer for regulating smooth muscle tone
12/08/2005US20050272825 Methods for the inhibition of atrophy or for treatment or prevention of atrophy-related symptoms in women
12/08/2005US20050272783 Amino acids with affinity for the alpha2delta-protein
12/08/2005US20050272733 1-substituted pyridine-2-ones or 2-substituted pyridazin-3-ones; anticarcinogenic agents for breast and prostate cancer; contraceptives; endometriosis, benign prostatic hypertophy
12/08/2005US20050272718 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
12/08/2005US20050272708 phosphoinositol ether lipid analogues and bioisosteres thereof;serine/threonine kinase (protein kinase B (PKB)) inhibitor; antitumor and anticarcinogenic agent; decreasing phosphorylation, increasing apoptosis in a tumor cell, and inhibiting pleckstrin homology (PH) domain binding
12/08/2005US20050272636 Treatment and diagnosis of a reproductive disorder by measuring or inhibiting interferon-gamma
12/08/2005US20050271756 Plant extraction method and extract
12/08/2005US20050271743 Treatment of inflammatory skin conditions
12/08/2005DE60017281T2 Nomegestrolacetat und östrogen enthaltende Hormonzusammensetzung und ihre Verwendung Nomegestrol acetate and estrogen hormone-containing composition and its use
12/08/2005CA2569320A1 Drug for ameliorating male climacteric disorder
12/08/2005CA2568050A1 Indazole and indolone derivatives and their use as pharmaceuticals
12/08/2005CA2568009A1 Use of ppar agonists to treat ruminants
12/08/2005CA2567398A1 New use
12/07/2005EP1602657A2 Substituted 9-alkyladenines
12/07/2005EP1602379A1 Botulinum toxin B for treating spastic muscle
12/07/2005EP1602369A2 Bupropion Metabolites and Methods of their Synthesis and Use
12/07/2005EP1601782A2 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 8b (pde8b)
12/07/2005EP1379528A4 Pyrazolopyrimidines as therapeutic agents
12/07/2005EP1246828B1 Benzosulfones with calcium antagonist activity
12/07/2005EP1216241B1 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
12/07/2005EP1178812B1 Methods of making conditioned cell culture medium compositions
12/07/2005EP1147089B1 Phenylphenanthridines with pde-iv inhibiting activity
12/07/2005EP1077928B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
1 ... 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 ... 557